AU2001296029A1 - Pharmaceutical preparation of percutaneous absorption type - Google Patents
Pharmaceutical preparation of percutaneous absorption typeInfo
- Publication number
- AU2001296029A1 AU2001296029A1 AU2001296029A AU9602901A AU2001296029A1 AU 2001296029 A1 AU2001296029 A1 AU 2001296029A1 AU 2001296029 A AU2001296029 A AU 2001296029A AU 9602901 A AU9602901 A AU 9602901A AU 2001296029 A1 AU2001296029 A1 AU 2001296029A1
- Authority
- AU
- Australia
- Prior art keywords
- pharmaceutical preparation
- absorption type
- percutaneous absorption
- percutaneous
- type
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Botany (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000-339524 | 2000-11-07 | ||
JP2000339524 | 2000-11-07 | ||
PCT/JP2001/009496 WO2002038139A1 (en) | 2000-11-07 | 2001-10-30 | Pharmaceutical preparation of percutaneous absorption type |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001296029A1 true AU2001296029A1 (en) | 2002-05-21 |
Family
ID=18814588
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001296029A Abandoned AU2001296029A1 (en) | 2000-11-07 | 2001-10-30 | Pharmaceutical preparation of percutaneous absorption type |
Country Status (6)
Country | Link |
---|---|
US (1) | US20040028724A1 (en) |
EP (1) | EP1340496A4 (en) |
JP (1) | JP4057418B2 (en) |
AU (1) | AU2001296029A1 (en) |
CA (1) | CA2428181A1 (en) |
WO (1) | WO2002038139A1 (en) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030206958A1 (en) * | 2000-12-22 | 2003-11-06 | Cattaneo Maurizio V. | Chitosan biopolymer for the topical delivery of active agents |
WO2002038139A1 (en) * | 2000-11-07 | 2002-05-16 | Hisamitsu Pharmaceutical Co., Inc. | Pharmaceutical preparation of percutaneous absorption type |
US7988991B2 (en) * | 2001-03-07 | 2011-08-02 | Hisamitsu Pharmaceutical Co., Inc. | Adhesive patch |
JP4354678B2 (en) * | 2002-08-28 | 2009-10-28 | 久光製薬株式会社 | Patch |
JP4792193B2 (en) * | 2002-08-28 | 2011-10-12 | 久光製薬株式会社 | Patch |
JP4213432B2 (en) * | 2002-08-28 | 2009-01-21 | 久光製薬株式会社 | Patch |
US20070073338A1 (en) * | 2003-09-04 | 2007-03-29 | Roy Raghunandan | Supercutaneous method and device for promoting hemostasis in cannulated patient |
TW200514582A (en) * | 2003-10-31 | 2005-05-01 | Hisamitsu Pharmaceutical Co | Transdermal preparation and method for reducing side effect in pergolide therapy |
US20080038328A1 (en) * | 2004-05-28 | 2008-02-14 | Naruhito Higo | Pasting Preparation |
WO2005117886A1 (en) * | 2004-06-01 | 2005-12-15 | Hisamitsu Pharmaceutical Co., Inc. | Adhesive patch |
DE602005020393D1 (en) * | 2004-06-01 | 2010-05-20 | Hisamitsu Pharmaceutical Co | Adhesive plaster |
JP4986411B2 (en) * | 2004-06-01 | 2012-07-25 | 久光製薬株式会社 | Patch |
US20060110415A1 (en) * | 2004-11-22 | 2006-05-25 | Bioderm Research | Topical Delivery System for Cosmetic and Pharmaceutical Agents |
JP5084496B2 (en) * | 2005-02-04 | 2012-11-28 | 久光製薬株式会社 | Transdermal patch |
WO2006093139A1 (en) | 2005-02-28 | 2006-09-08 | Hisamitsu Pharmaceutical Co., Inc. | Transdermally absorbable preparation |
JP5122445B2 (en) | 2006-05-08 | 2013-01-16 | 帝國製薬株式会社 | Transdermal absorption preparation of antidementia drug |
US8580281B2 (en) | 2008-02-27 | 2013-11-12 | Hisamitsu Pharmaceutical Co., Inc. | Medicated patch |
ES2661767T3 (en) | 2008-02-27 | 2018-04-03 | Hisamitsu Pharmaceutical Co., Inc. | Adhesive skin patch and packaged product |
US20110189261A1 (en) * | 2008-03-03 | 2011-08-04 | Hisamitsu Pharmaceutical Co., Inc. | Transdermally absorbable preparation |
JP5368168B2 (en) * | 2008-06-16 | 2013-12-18 | 日東電工株式会社 | Patches and patch preparations |
ITMI20081652A1 (en) * | 2008-09-16 | 2010-03-17 | Antica Ritrovati Medicinal I S A R M Srl Soc | TRANSDERMIC COMPOSITIONS FOR HYPOSENSIBILIZING SPECIFIC IMMUNOTHERAPY |
CN105419206B (en) * | 2009-07-30 | 2017-12-15 | 赢创罗姆有限公司 | Powdered or granular composition comprising copolymer, dicarboxylic acids and aliphatic mono-carboxylic acids |
WO2011012161A1 (en) | 2009-07-30 | 2011-02-03 | Evonik Röhm Gmbh | Powdery or granulated composition comprising a copolymer, a dicarboxylic acid and a fatty monocarboxylic acid |
EP2514414A4 (en) * | 2009-12-16 | 2013-05-29 | Goto Takeshi | Transdermally absorbed preparation of anti-dementia drug |
WO2011074637A1 (en) | 2009-12-16 | 2011-06-23 | 後藤 武 | Transdermally absorbed preparation of anti-dementia drug |
JP2012236773A (en) * | 2009-12-16 | 2012-12-06 | Goto Takeshi | Transdermally absorbable preparation of anti-dementia drug |
JP5631854B2 (en) * | 2010-12-13 | 2014-11-26 | 久光製薬株式会社 | Pharmaceutical composition and patch |
JP5906302B2 (en) | 2011-03-24 | 2016-04-20 | テイコク ファーマ ユーエスエー インコーポレーテッド | Transdermal composition comprising an agent layer and an agent conversion layer |
KR101856515B1 (en) | 2012-11-02 | 2018-05-10 | 테이코쿠 팔마 유에스에이, 인코포레이티드 | Propynylaminoindan transdermal compositions |
US9980920B2 (en) | 2013-09-11 | 2018-05-29 | Medrx Co., Ltd. | Base composition for tape agent |
JPWO2017094337A1 (en) * | 2015-12-04 | 2018-09-20 | ニチバン株式会社 | Patch |
US9993466B2 (en) * | 2016-07-27 | 2018-06-12 | Corium International, Inc. | Donepezil transdermal delivery system |
EP3818982B1 (en) * | 2018-01-31 | 2023-12-20 | Medrx Co., Ltd. | Tizanidine therapy system |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1413186A (en) * | 1973-06-27 | 1975-11-12 | Toyo Jozo Kk | Process for encapsulation of medicaments |
US5364628A (en) * | 1985-05-31 | 1994-11-15 | Sandoz Ltd. | Pharmaceutical compositions |
DE3581428D1 (en) * | 1984-06-13 | 1991-02-28 | Roehm Gmbh | METHOD FOR COVERING MEDICINAL FORMS. |
US5045553A (en) * | 1987-06-24 | 1991-09-03 | Fujisawa Pharmaceutical Company, Ltd. | Pharmaceutical composition for percutaneous drug absorption and percutaneous drug absorption promoter |
US5656286A (en) * | 1988-03-04 | 1997-08-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
US5474783A (en) * | 1988-03-04 | 1995-12-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
DE69009540T2 (en) * | 1989-03-15 | 1994-09-29 | Nitto Denko Corp | Adhesive plasters containing medicines. |
US5462744A (en) * | 1989-12-01 | 1995-10-31 | Boehringer Ingelheim Kg | Transdermal system for the administration of pharmacological compounds under pH-controlled conditions |
JP2977254B2 (en) | 1990-09-04 | 1999-11-15 | 積水化学工業株式会社 | Transdermal patch |
JP3253431B2 (en) * | 1993-09-29 | 2002-02-04 | 積水化学工業株式会社 | Medical patch |
JP3908795B2 (en) * | 1994-11-29 | 2007-04-25 | 久光製薬株式会社 | Ketotifen-containing transdermal preparation |
TW487582B (en) * | 1995-08-11 | 2002-05-21 | Nissan Chemical Ind Ltd | Method for converting sparingly water-soluble medical substance to amorphous state |
AU4320997A (en) * | 1996-09-26 | 1998-04-17 | Hokuriku Seiyaku Co. Ltd | Percutaneous preparations |
DE19653606A1 (en) * | 1996-12-20 | 1998-06-25 | Roehm Gmbh | Adhesive and binder made from (meth) acrylate polymer, organic acid and plasticizer |
JPH1112177A (en) * | 1997-06-25 | 1999-01-19 | Teikoku Seiyaku Co Ltd | Stable aspirin-containing preparation for external use |
JP4205778B2 (en) * | 1998-04-17 | 2009-01-07 | 久光製薬株式会社 | Patch preparation |
JP4275768B2 (en) | 1998-06-18 | 2009-06-10 | 久光製薬株式会社 | Aqueous adhesive paste |
IT1317736B1 (en) * | 2000-01-26 | 2003-07-15 | A C R Applied Coating Res S A | PATCH FOR LOCAL AND TRANSDERMAL ADMINISTRATION OF PRINCIPIACTIVES EQUIPPED WITH ANIONIC GROUPS AND ELECTRONATTRACTORS. |
WO2002038139A1 (en) * | 2000-11-07 | 2002-05-16 | Hisamitsu Pharmaceutical Co., Inc. | Pharmaceutical preparation of percutaneous absorption type |
-
2001
- 2001-10-30 WO PCT/JP2001/009496 patent/WO2002038139A1/en active Application Filing
- 2001-10-30 JP JP2002540725A patent/JP4057418B2/en not_active Expired - Lifetime
- 2001-10-30 US US10/416,628 patent/US20040028724A1/en not_active Abandoned
- 2001-10-30 CA CA002428181A patent/CA2428181A1/en not_active Abandoned
- 2001-10-30 EP EP01976871A patent/EP1340496A4/en not_active Withdrawn
- 2001-10-30 AU AU2001296029A patent/AU2001296029A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP4057418B2 (en) | 2008-03-05 |
JPWO2002038139A1 (en) | 2004-03-11 |
EP1340496A1 (en) | 2003-09-03 |
WO2002038139A1 (en) | 2002-05-16 |
EP1340496A4 (en) | 2004-04-14 |
CA2428181A1 (en) | 2002-05-16 |
US20040028724A1 (en) | 2004-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001296029A1 (en) | Pharmaceutical preparation of percutaneous absorption type | |
AU2001237526A1 (en) | Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof | |
AU2001237525A1 (en) | Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same | |
AU2002225855A1 (en) | Preparation of nanocrystallites | |
DZ3311A1 (en) | Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof | |
DZ3313A1 (en) | Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same | |
AU2001235691A1 (en) | Use of paullone derivatives for making medicines | |
AU2003246810A1 (en) | Diphenylpyridine derivatives, the preparation thereof, and pharmaceutical compositions containing said derivatives | |
AU2001250420A1 (en) | Pharmaceutical compositions | |
AU2001274307A1 (en) | Pharmaceutical compositions | |
AU2002214324A1 (en) | Medicinal compositions | |
AU2001290239A1 (en) | Medicinal composition | |
AU2002221115A1 (en) | Medicinal compositions having improved absorbability | |
AU2001292331A1 (en) | 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation | |
AU2001292331A2 (en) | 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation | |
AU2001273919A1 (en) | Pharmaceutical compositions | |
AU2001227084A1 (en) | N-arylhydrazide compounds and use thereof as drugs | |
AU2001284763A1 (en) | Preparation of risperidone | |
AU4085201A (en) | Pharmaceutical composition | |
AU2001292578A1 (en) | Pharmaceutical compounds | |
AU2001250625A1 (en) | 19-norbufalin derivatives, their preparation and pharmaceutical compositions containing them | |
AU3586401A (en) | Pharmaceutical composition | |
AU2001278705A1 (en) | Pharmaceutical composition | |
AU2001292001A1 (en) | Pharmaceutical oxan preparation | |
AU2001237518A1 (en) | Polyfluoroalkylimidazole derivatives, their preparation and therapeutic application |